On the public citation graph

Drug Discovery in an Academic Setting: Playing to the Strengths

https://doi.org/10.1021/ml400012g
0 signed · 31 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/anie.201204625openalex-snapshot
Challenges for Academic Drug Discovery
inferredcites →https://doi.org/10.1021/ml3000116openalex-snapshot
Future Horizons in Drug Discovery Research
inferredcites →https://doi.org/10.1038/nrd3462openalex-snapshot
US academic drug discovery
inferredcites →https://doi.org/10.4155/fmc.10.237openalex-snapshot
Observations on Screening-Based Research and Some Concerning Trends in the Literature
inferredcites →https://doi.org/10.4155/fmc.11.44openalex-snapshot
Growing PAINS in Academic Drug Discovery

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/0471266949.bmc292openalex-snapshot
Experiences in Academic and Industry Partnerships – Forging a Path to Translational Drug Discovery
inferred← citeshttps://doi.org/10.1002/9781118771723.ch3openalex-snapshot
Access to Compound Collections
inferred← citeshttps://doi.org/10.1002/9781118819586.ch12openalex-snapshot
Impact of Investment Strategies, Organizational Structure and Corporate Environment on Attrition, and Future Investment Strategies to Reduce Attrition
inferred← citeshttps://doi.org/10.1002/9783527683604.ch10openalex-snapshot
Making FBDD Work in Academia
inferred← citeshttps://doi.org/10.1007/978-1-4939-2269-7_17openalex-snapshot
Practical Strategies for Small-Molecule Probe Development in Chemical Biology
inferred← citeshttps://doi.org/10.1016/b978-0-12-801814-9.00015-5openalex-snapshot
Collaborative Strategies for Future Drug Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-12-824304-6.00025-0openalex-snapshot
Drug discovery processes: When and where the rubber meets the road
inferred← citeshttps://doi.org/10.1016/bs.mie.2018.09.012openalex-snapshot
Risk Management in Early Discovery Medicinal Chemistry
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.05.014openalex-snapshot
NIPTE: a multi-university partnership supporting academic drug development
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.04.016openalex-snapshot
Development of cell therapy medicinal products by academic institutes
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00885openalex-snapshot
Navigating the Landscape of Academic Drug Discovery: An 18-Year Journey
inferred← citeshttps://doi.org/10.1021/acs.joc.4c00652openalex-snapshot
My 50-Plus Years of Academic Research Collaborations with Industry. A Retrospective
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.0c00006openalex-snapshot
The Resurrection of Phenotypic Drug Discovery
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.9b00107openalex-snapshot
A Medicinal Chemist’s Perspective on Transitioning from Industry to Academic Drug Discovery
inferred← citeshttps://doi.org/10.1021/jm400132dopenalex-snapshot
Contributions of Academic Laboratories to the Discovery and Development of Chemical Biology Tools
inferred← citeshttps://doi.org/10.1021/jm401564ropenalex-snapshot
Discovery of Innovative Therapeutics: Today’s Realities and Tomorrow’s Vision. 2. Pharma’s Challenges and Their Commitment to Innovation
inferred← citeshttps://doi.org/10.1038/nrd4578openalex-snapshot
Mitigating risk in academic preclinical drug discovery
inferred← citeshttps://doi.org/10.1111/cts.12175openalex-snapshot
Academic Medical Product Development: An Emerging Alliance of Technology Transfer Organizations and the CTSA
inferred← citeshttps://doi.org/10.1111/cts.12577openalex-snapshot
The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development
inferred← citeshttps://doi.org/10.1182/asheducation-2013.1.300openalex-snapshot
Drug discovery in academic institutions
inferred← citeshttps://doi.org/10.1517/17460441.2015.1059816openalex-snapshot
Academic drug discovery: current status and prospects
inferred← citeshttps://doi.org/10.2217/fvl-2015-0011openalex-snapshot
Consortia’s Critical Role in Developing Medical Countermeasures for re-emerging Viral Infections: A Usa Perspective
inferred← citeshttps://doi.org/10.4091/iken.2017.001openalex-snapshot
Issues in Academic Drug Discovery
inferred← citeshttps://doi.org/10.4155/fdd-2019-0006openalex-snapshot
Forward-Looking Perspective On Publishing in Drug Discovery
inferred← citeshttps://doi.org/10.4155/ppa.13.31openalex-snapshot
Small-molecule Inhibitors of IκB Kinase (IKK) and IKK-related Kinases
inferred← citeshttps://doi.org/10.5336/pharmsci.2015-48211openalex-snapshot
The Role of Importance of Medicinal Chemistry in Novel Drug Discovery and Development: Review
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.